Qiagen stock trades at EUR 45.01 as EQT offer sets EUR 46.50
Published on 10/24/2026 at 10:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTakeover timeline and results
- QIAGEN agreed to a EUR 46.50 cash offer on October 21, 2026.
- QIAGEN stock trades at EUR 45.01 in weekend trading at 10:17 a.m. CEST on October 24, 2026.
- QIAGEN plans to publish full third-quarter results on November 4, 2026.
QIAGEN and EQT Private Equity agreed on October 21, 2026, to a recommended voluntary all-cash public takeover offer of EUR 46.50 per QIAGEN share, according to Business Wire. QIAGEN's Managing Board and Supervisory Board approved the agreement and agreed to recommend acceptance.
QIAGEN stock is at EUR 45.01 in weekend trading at Lang & Schwarz at 10:17 a.m. CEST on October 24, 2026. The quote is below the EUR 46.50 offer price. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Qiagen stock.
Market context: Market report DAX.
Transaction terms
The transaction values QIAGEN at approximately EUR 10.8 billion in enterprise value. Completion is expected in mid-2027 and is subject to conditions including a minimum acceptance threshold of 50% of QIAGEN's outstanding share capital plus one share and regulatory clearances, the company said in the Business Wire release.
QIAGEN also reported preliminary third-quarter 2026 results. Net sales were USD 548 million at both reported and constant exchange rates, while adjusted diluted earnings per share were USD 0.65 on both bases. QIAGEN suspended its full-year 2026 outlook while the transaction is pending, according to the EQS-distributed issuer announcement published on October 21, 2026: EQS.
Next reporting date
QIAGEN plans to report its full third-quarter 2026 results on November 4, 2026, according to the Business Wire release.
